{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:25:49Z","timestamp":1781961949733,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T00:00:00Z","timestamp":1336694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s10552-012-9977-y","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T04:44:45Z","timestamp":1336625085000},"page":"1083-1089","source":"Crossref","is-referenced-by-count":12,"title":["Medical conditions and risk of adult myeloid leukemia"],"prefix":"10.1007","volume":"23","author":[{"given":"Kimberly J.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy M.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Roesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy A.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong L.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,11]]},"reference":[{"issue":"5","key":"9977_CR1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","volume":"100","author":"LA Anderson","year":"2009","unstructured":"Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA (2009) Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer 100(5):822\u2013828","journal-title":"Br J Cancer"},{"issue":"4","key":"9977_CR2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1572-0241.1999.01012.x","volume":"94","author":"P Karlen","year":"1999","unstructured":"Karlen P, Lofberg R, Brostrom O, Leijonmarck CE, Hellers G, Persson PG (1999) Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 94(4):1047\u20131052","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"9977_CR3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1542-3565(04)00543-9","volume":"2","author":"KV Winther","year":"2004","unstructured":"Winther KV, Jess T, Langholz E, Munkholm P, Binder V (2004) Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol 2(12):1088\u20131095","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"9977_CR4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/gut.2004.051771","volume":"54","author":"J Askling","year":"2005","unstructured":"Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R et al (2005) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54(5):617\u2013622","journal-title":"Gut"},{"issue":"6","key":"9977_CR5","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ijc.23666","volume":"123","author":"K Hemminki","year":"2008","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K (2008) Cancer risks in ulcerative colitis patients. Int J Cancer 123(6):1417\u20131421","journal-title":"Int J Cancer"},{"issue":"21","key":"9977_CR6","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1200\/JCO.2011.34.8540","volume":"29","author":"SY Kristinsson","year":"2011","unstructured":"Kristinsson SY, Bjorkholm M, Hultcrantz M, Derolf AR, Landgren O, Goldin LR (2011) Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol 29(21):2897\u20132903","journal-title":"J Clin Oncol"},{"issue":"10","key":"9977_CR7","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","volume":"64","author":"J Askling","year":"2005","unstructured":"Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A et al (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64(10):1414\u20131420","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"9977_CR8","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1158\/1055-9965.EPI-11-0411","volume":"20","author":"JA Ross","year":"2011","unstructured":"Ross JA, Blair CK, Cerhan JR, Soler JT, Hirsch BA, Roesler MA et al (2011) Nonsteroidal anti-inflammatory drug and acetaminophen use and risk of adult myeloid leukemia. Cancer Epidemiol Biomarkers Prev 20(8):1741\u20131750","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"9977_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/1047-2797(94)00113-8","volume":"5","author":"ML Slattery","year":"1995","unstructured":"Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD (1995) Response rates among control subjects in case\u2013control studies. Ann Epidemiol 5(3):245\u2013249","journal-title":"Ann Epidemiol"},{"issue":"9","key":"9977_CR10","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/ibd.21205","volume":"16","author":"KK Das","year":"2010","unstructured":"Das KK, Nishino HT, Chan AT (2010) Treatment-associated acute myeloid leukemia in a patient with Crohn\u2019s disease on 6-mercaptopurine. Inflamm Bowel Dis 16(9):1454\u20131456","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"9977_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1470-2045(08)70286-9","volume":"10","author":"Y Grosse","year":"2009","unstructured":"Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Bouvard V et al (2009) A review of human carcinogens-Part A: pharmaceuticals. Lancet Oncol 10(1):13\u201314","journal-title":"Lancet Oncol"},{"issue":"17","key":"9977_CR12","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/0008-5472.CAN-09-0451","volume":"69","author":"T Nguyen","year":"2009","unstructured":"Nguyen T, Vacek PM, O\u2019Neill P, Colletti RB, Finette BA (2009) Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease. Cancer Res 69(17):7004\u20137012","journal-title":"Cancer Res"},{"issue":"1","key":"9977_CR13","doi-asserted-by":"crossref","first-page":"e2011020","DOI":"10.4084\/mjhid.2011.020","volume":"3","author":"K Schmiegelow","year":"2011","unstructured":"Schmiegelow K (2011) Epidemiology of therapy-related myeloid neoplasms after treatment for pediatric acute lymphoblastic leukemia in the nordic countries. Mediterr J Hematol Infect Dis 3(1):e2011020","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"9977_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004836-198009000-00003","volume":"2","author":"TL Fabry","year":"1980","unstructured":"Fabry TL, Sachar DB, Janowitz HD (1980) Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol 2(3):225\u2013227","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"9977_CR15","first-page":"1913","volume":"25","author":"AO Karaoglu","year":"2004","unstructured":"Karaoglu AO, Kadikoylu G, Yukselen V, Yasa MH, Bolaman Z (2004) Gastrointestinal lesions and Helicobacter pylori in patients with myeloproliferative disorders. Saudi Med J 25(12):1913\u20131916","journal-title":"Saudi Med J"},{"issue":"6","key":"9977_CR16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/00313020500370192","volume":"37","author":"AE Grulich","year":"2005","unstructured":"Grulich AE, Vajdic CM (2005) The epidemiology of non-Hodgkin lymphoma. Pathology 37(6):409\u2013419","journal-title":"Pathology"},{"issue":"7","key":"9977_CR17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/aje\/kwi261","volume":"162","author":"M Lehtinen","year":"2005","unstructured":"Lehtinen M, Ogmundsdottir HM, Bloigu A, Hakulinen T, Hemminki E, Gudnadottir M et al (2005) Associations between three types of maternal bacterial infection and risk of leukemia in the offspring. Am J Epidemiol 162(7):662\u2013667","journal-title":"Am J Epidemiol"},{"key":"9977_CR18","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780195149616.001.0001","volume-title":"Cancer epidemiology and prevention","author":"D Schottenfeld","year":"2006","unstructured":"Schottenfeld D, Fraumeni JF (2006) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Oxford","edition":"3"},{"issue":"2 Suppl","key":"9977_CR19","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","volume":"137","author":"DL Preston","year":"1994","unstructured":"Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A et al (1994) Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950\u20131987. Radiat Res 137(2 Suppl):S68\u2013S97","journal-title":"Radiat Res"},{"issue":"3","key":"9977_CR20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12185-012-1002-4","volume":"95","author":"H Tsushima","year":"2012","unstructured":"Tsushima H, Iwanaga M, Miyazaki Y (2012) Late effect of Atomic bomb radiation on myeloid disorders: leukemia and myelodysplastic syndromes. Int J Hematol 95(3):232\u2013238","journal-title":"Int J Hematol"},{"issue":"3","key":"9977_CR21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-006-9460-0","volume":"105","author":"RA Howard","year":"2007","unstructured":"Howard RA, Gilbert ES, Chen BE, Hall P, Storm H, Pukkala E et al (2007) Leukemia following breast cancer: an international population-based study of 376,825 women. Breast Cancer Res Treat 105(3):359\u2013368","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"9977_CR22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1726-4901(09)70213-8","volume":"68","author":"KL Wang","year":"2005","unstructured":"Wang KL, Lin LY, Chen PM, Lin HD (2005) Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma. J Chin Med Assoc 68(5):230\u2013233","journal-title":"J Chin Med Assoc"},{"issue":"5","key":"9977_CR23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/10428190290021533","volume":"43","author":"F Bauduer","year":"2002","unstructured":"Bauduer F, Ducout L, Dastugue N, Marolleau JP (2002) Chronic myeloid leukemia as a secondary neoplasm after anti-cancer radiotherapy: a report of three cases and a brief review of the literature. Leuk Lymphoma 43(5):1057\u20131060","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"9977_CR24","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2169\/internalmedicine.47.1072","volume":"47","author":"M Tsuzuki","year":"2008","unstructured":"Tsuzuki M, Handa K, Yamamoto K, Hasegawa A, Yamamoto Y, Watanabe M et al (2008) Chronic myeloid leukemia following chemotherapy with 5\u2032-deoxy-5-fluorouridine for gastric cancer. Intern Med 47(19):1739\u20131741","journal-title":"Intern Med"},{"key":"9977_CR25","doi-asserted-by":"crossref","unstructured":"Health Pm. Ulcerative Colitis. 2011 [cited 2011 11\/4\/2011]","DOI":"10.1093\/med\/9780198569862.003.0044"},{"issue":"6","key":"9977_CR26","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus Jr","year":"2004","unstructured":"Loftus EV Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126(6):1504\u20131517","journal-title":"Gastroenterology"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-9977-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-012-9977-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-9977-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T13:14:29Z","timestamp":1561727669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-012-9977-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["9977"],"URL":"https:\/\/doi.org\/10.1007\/s10552-012-9977-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]}}}